| Basic data
|
| (21) | Request Number: | S20240024A (Request for grant of Supplementary Protection Certificate pending) |
| (22) | Request Date: | 04.07.2024 |
| (43) | Request Publication Date: | 19.07.2024 |
| |
| (71) | Applicant(s): | | 1. | ARRAY BIOPHARMA INC., 3200 Walnut Street, Boulder, CO 80301, US | | 2. | MIRATI THERAPEUTICS, INC., 9393 Towne Centre Drive, Suite 200, San Diego, CA 92121, US |
|
| (74) | Representative: | CPZ - CENTAR ZA PATENTE d.o.o.,
Kutinska 2, 10000 Zagreb, HR
|
| |
| (68) | Basic Patent Number: | P20230377 |
| (21) | Application Number | P20230377A |
| (22) | Filing Date | 17.04.2023 |
| (54) | Title of Invention: | KRAS G12C INHIBITORS |
| |
| (95) | Product Name: | ADAGRASIB ILI NJEGOVA FARMACEUTSKI PRIHVATLJIVA SOL |
| |
| (92)(93) | Number and Date of First Marketing Authorisation: | |
| |
| |